Detailed Analysis Accumulated Losses

Ekttitab Holding Company reported accumulated losses of KWD 23,815,000 as of Q2 2026, representing 74.74% of its paid-up capital.
Shareholders approved a capital reduction from KWD 31,862,423 to KWD 8,131,223 on June 24, 2026, to fully offset accumulated losses as of December 31, 2025, by cancelling 237,312,000 shares.
The company utilized its entire statutory reserve balance of KWD 94,506 to partially offset losses following General Assembly approval on May 24, 2026.
Ongoing recovery initiatives include restructuring assets and liabilities over a two-year period, alongside revenue growth and cost rationalization measures intended to be implemented within one fiscal year.